Company news

Sirnaomics Ltd. news in 2023

Sirnaomics Ltd.'s news releases, calls and decks from 2023, newest first.

View company

Sirnaomics Announces Successful Completion of Cohort 1 from Phase I Clinical Study of GalNAc-Based RNAi Therapeutic STP122G for Anticoagulant Treatment

December 5, 2023

Sirnaomics Promotes Francois Lebel, M.D. to Chief Medical Officer

December 1, 2023

Sirnaomics Presents Positive Clinical Data of STP705 for Focal Fat Reduction

November 1, 2023

Sirnaomics Announces Successful Phase I Clinical Study of RNAi Therapeutic STP707 for Treatment of Multiple Solid Tumors

August 30, 2023

Sirnaomics Appoints Dr. Francois Lebel as Senior Vice President for Preclinical and Clinical Development

July 27, 2023

Sirnaomics to Present Latest Developments on Two Proprietary Delivery Platforms at Upcoming Industry Conferences

July 12, 2023

Sirnaomics Establishes a Strategic Partnership with EDIRNA Inc., an RNA-Editing Therapeutic Company

July 5, 2023

Sirnaomics Advances STP705 for Squamous Cell Carcinoma In Situ into Late-Stage Clinical Development

June 19, 2023

Sirnaomics Reports Interim Results of STP705 Phase I Clinical Study for Medical Aesthetics Treatment in Adults Undergoing Abdominoplasty

June 5, 2023

Decks in 2023